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period. The episode ended if an inpatient visit was
recorded. Hospitalisation costs were estimated according
to age-group CMG-speciﬁc resource intensity weights.
RESULTS: Of 10,565 subjects, 10.1% were deemed to 
be treatment failure. For subjects without failure, mean
treatment cost was $69.95 (SD = 20.70) compared with
$515.81 (SD = 911.03). The results of multiple regression
on log-transformed total costs using as independent vari-
ables the type of antibiotic initially prescribed, age group,
gender, diagnosis and chronic disease score, suggest that
age 75+, diagnosis of pneumonia (contrasted to bron-
chitis), and a chronic disease score of 4+ are associated
with increased total cost. Use of cephalosporins, 
clarithromycin 500 and quinolones were associated with
higher total cost than use of azithromycin 250mg. Use 
of clarithromycin 250, erythromycin, amoxicillin, other
penicillins, trimethoprim-sulfas and other antibiotics
were associated with lower total cost than use of
azithromycin 250mg.
CONCLUSIONS: Total cost of treatment of LRTI in
seniors is associated with older age, high disease score,
and type of antibiotic used.
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Acute Otitis Media (AOM) is the most common medical
condition in children and results in 30 million physician
visits annually. Clinical practice guidelines call for use 
of well-established ﬁrst-line antibiotics for treatment in
spite of the introduction of several newer second-line
antibiotics.
OBJECTIVE: This study sought to determine the impact
of antibiotic prescribing at initial visit on the probability
and frequency of AOM-related return visits among North
Carolina Medicaid patients.
METHODS: We identiﬁed new episodes of AOM among
continuously eligible patients below age 7 over a 1-year
period ending August 2000. We matched prescriptions
dispensed up to 3 days after the medical visit and we clas-
siﬁed patients as having received ﬁrst-line or second-line
antibiotic, based on CDC practice guidelines. We identi-
ﬁed return visits as those occurring within 30 days of the
index visit. Using a two-part model we estimated two
equations that modeled, ﬁrst, the probability of a return
visit and second, the log-transformed frequency of return
visits among patients with a return visit, adjusting for
clustering of errors at the provider level. Independent
variables included treatment group, patient demograph-
ics, physician specialty, practice site, and seasonality.
RESULTS: A total of 52,556 recipients received an 
antibiotic prescription at an AOM-related index visit 
from 1,617 providers, 66% of whom were pediatricians.
First-line antibiotics accounted for 65% of antibiotics
prescribed at index visit. The average annual antibiotic
expenditure for patients dispensed ﬁrst-line antibiotics at
index visit was $12 and $42 for patients receiving second-
line antibiotics. Patients receiving ﬁrst-line antibiotics had
a lower probability of (OR = 0.78, 95% CI [0.74, 0.82])
and fewer return visits (3%, p-value <0.001), as com-
pared to patients receiving second-line antibiotics.
CONCLUSIONS: First-line antibiotics were associated
with a lower probability and frequency of return visits as
compared to second-line antibiotics. However, only 65%
of initial visits resulted in a prescription for a ﬁrst-line
antibiotics. Given the better treatment outcomes and
lower costs, considerable cost-saving potential exists if
physicians were encouraged to prescribe ﬁrst-line antibi-
otics more often for initial AOM visits.
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OBJECTIVE: To estimate the burden of illness of Acute
Bacterial Sinusitis (ABS) to health care providers. 
Background: ABS is a common secondary infection, with
roughly 20 million cases annually in the US. Thus, the
treatment of ABS is associated with signiﬁcant health
resource utilizations.
METHODS: Using clinical trial data of drug therapies 
for ABS, the health resource utilization patterns such 
as Medical Doctor (MD) time, Registered Nurse and
Physician Assistant (RN&PA) time, and Ofﬁce Staff time
(OS) spent on treatment-related call backs for the 10 day
follow-up period, are examined by the economic value of
this time is measured based on nationally reported wage
rates for each category.
RESULTS: Of 792 patients that were valid for efﬁcacy,
the demographic information from the data shows mean
age of 44.26 (SD 15.45), 64% female, 94% Caucasians,
and 5% African Americans. Twenty-one percent of the
patients called back in the 10-day follow-up period. For
these patients with call back, 8.91 minutes (SD 7.37) was
for MD time, 6.59 minutes (SD 8.85) of RN&PA time,
and 4.24 minutes (SD 5.55) of OS time were recorded on
average. Including the other 79% of patients who did not
call back, the average time spent on the sum of all three
categories was 4.11 minutes (SD 11.59). These numbers
can be translated into the average follow-up wage cost
for health care professions of $2.15 (SD 5.75) per person
with ABS. For 20 million cases, this number implies $43
million total wage cost for the health care side. 
CONCLUSION: ABS is so common that it causes a 
signiﬁcant burden in terms of health care resource 
utilization. The burden is signiﬁcant not only in terms of
the initial physician visit, but also in terms of follow up
visits and call-backs.
